AUTL

Autolus Therapeutics
AUTL

Overview Fund Activity

98 hedge funds and large institutions have $747M invested in Autolus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 5 closing their positions.

Holders
98
Holders Change
+28
Holders Change %
+40%
% of All Funds
1.44%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
34
Increased
21
Reduced
19
Closed
5
Calls
$1.52M
Puts
$21K
Net Calls
+$1.5M
Net Calls Change
+$1.14M

Top Buyers

1
CAM
1
Cormorant Asset Management
Massachusetts
$35.1M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$24.6M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$19.3M
4
PA
4
Perceptive Advisors
New York
$11.8M
5
FAM
5
Fred Alger Management
New York
$8.72M

Top Sellers

1
TAM
1
TFG Asset Management
Cayman Islands
$51.5M
2
DTC
2
Deep Track Capital
Connecticut
$76.4M
3
AC
3
Armistice Capital
New York
$24.8M
4
PBA
4
Paradigm Biocapital Advisors
New York
$81.2M
5
DCM
5
DAFNA Capital Management
California
$1.23M
Name Holding Trade Value Shares
Change 		Shares
Change %
FWM
101
Focused Wealth Management
New York
– -$11.7K -5,000 Closed
UIA
102
Ulland Investment Advisors
Minnesota
– -$2K -1,000 Closed
1 2 3 4
5